siRNA, Anti-CDK11A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo-modified(CAT#: SIRGT66841WQ-2OMe)

The product SIRGT66841WQ-2OMe is a type of small interfering RNA (siRNA) that targets CDK11A gene and regulates the expression of gene. The siRNA interferes with the expression of CDK11A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001313896.1
Alternative Names CDC2L2; CDC2L3; CDK11-p110; CDK11-p46; CDK11-p58; PITSLRE; p58GTA
Related Diseases Childhood Endodermal Sinus Tumor
Purification HPLC
Target Gene
Gene ID 728642
Uniprot ID Q9UQ88
Sub Cat Target Species Modification Scale  
SIRGT67841WQ-2F CDK11A Human 2ʹ-O-methyl (2'-OMe) Inquiry
SIRGT68841WQ-2MOE CDK11A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT69841WQ-LNA CDK11A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT67841WQ-RB CDK11A Human Ribo-modified Inquiry

Related Products